Publications by authors named "Rajiv Bassi"

Claim this Profile
P
Preclinical rationale for combining an EGFR antibody with cisplatin/gemcitabine for the treatment of NSCLC.
Selda Samakoglu, Dhanvanthri S Deevi, Huiling Li, Su Wang, Mary Murphy, Rajiv Bassi

Cancer Genomics Proteomics· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating preclinical efficacy targets utilizing cetuximab efficacy in KRAS mutant and wild-type colorectal cancer models.
Marie Prewett, Rajiv Bassi, Keren Paz, Michael Amatulli, Dhanvanthri Deevi

Anticancer Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-transforming growth factor beta receptor II antibody has therapeutic efficacy against primary tumor growth and metastasis through multieffects on cancer, stroma, and immune cells.
Zhaojing Zhong, Kyla Driscoll Carroll, Desiree Policarpio, Carla Osborn, Michael Gregory, Rajiv Bassi

Clin Cancer Res· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a fully human anti-PDGFRbeta antibody that suppresses growth of human tumor xenografts and enhances antitumor activity of an anti-VEGFR2 antibody.
Juqun Shen, Marie Danielle Vil, Marie Prewett, Chris Damoci, Haifan Zhang, Rajiv Bassi

Neoplasia· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-epidermal growth factor receptor monoclonal antibody cetuximab inhibits EGFR/HER-2 heterodimerization and activation.
Dipa Patel, Rajiv Bassi, Andrea Hooper, Marie Prewett, Daniel J Hicklin

Int J Oncol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced suppression of melanoma tumor growth and metastasis by combined therapy with anti-VEGF receptor and anti-TYRP-1/gp75 monoclonal antibodies.
Dipa Patel, Rajiv Bassi, Andrea T Hooper, Haijun Sun, James Huber

Anticancer Res· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation and characterization of a therapeutic human antibody to melanoma antigen TYRP1.
Dipa Patel, Paul Balderes, Armin Lahiji, Maxine Melchior, Stanley Ng, Rajiv Bassi

Hum Antibodies· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumors established with cell lines selected for oxaliplatin resistance respond to oxaliplatin if combined with cetuximab.
Marie Prewett, Dhanvanthri S Deevi, Rajiv Bassi, Fan Fan, Lee M Ellis

Clin Cancer Res· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitory activity of cetuximab on epidermal growth factor receptor mutations in non small cell lung cancers.
Jacqueline F Doody, Ying Wang, Sheetal N Patel, Christopher Joynes, Sui Ping Lee, Rajiv Bassi

Mol Cancer Ther· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An antibody directed against PDGF receptor beta enhances the antitumor and the anti-angiogenic activities of an anti-VEGF receptor 2 antibody.
Juqun Shen, Marie D Vil, Haifan Zhang, James R Tonra, Ling L Rong, Rajiv Bassi

Biochem Biophys Res Commun· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor growth inhibition with cetuximab and chemotherapy in non-small cell lung cancer xenografts expressing wild-type and mutated epidermal growth factor receptor.
Philipp Steiner, Christopher Joynes, Rajiv Bassi, Su Wang, James R Tonra

Clin Cancer Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer.
Yan Wu, Zhaojing Zhong, James Huber, Rajiv Bassi, Bridget Finnerty

Clin Cancer Res· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member.
Jennifer M O'Toole, Karen E Rabenau, Kerri Burns, Dan Lu, Venkat Mangalampalli, Rajiv Bassi

Cancer Res· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fully human recombinant IgG-like bispecific antibody to both the epidermal growth factor receptor and the insulin-like growth factor receptor for enhanced antitumor activity.
Dan Lu, Haifan Zhang, Henry Koo, James Tonra, Paul Balderes, Rajiv Bassi

J Biol Chem· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conservation of receptor antagonist anti-tumor activity by epidermal growth factor receptor antibody expressed in transgenic corn seed.
Dale L Ludwig, Larry Witte, Daniel J Hicklin, Marie Prewett, Rajiv Bassi

Hum Antibodies· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the platelet-derived growth factor receptor alpha with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: implications as a potential therapeutic target.
Nick Loizos, Yan Xu, Jim Huber, Meilin Liu, Dan Lu, Rajiv Bassi

Mol Cancer Ther· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitory anti-FLT3 antibodies are capable of mediating antibody-dependent cell-mediated cytotoxicity and reducing engraftment of acute myelogenous leukemia blasts in nonobese diabetic/severe combined immunodeficient mice.
Obdulio Piloto, Mark Levis, David Huso, Yiwen Li, Hongli Li, Rajiv Bassi

Cancer Res· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of both the autocrine and the paracrine growth of human leukemia with a fully human antibody directed against vascular endothelial growth factor receptor 2.
Haifan Zhang, Yiwen Li, Hongli Li, Rajiv Bassi, Xenia Jimenez

Leuk Lymphoma· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of leukemia expressing wild-type or ITD-mutant FLT3 receptor by a fully human anti-FLT3 neutralizing antibody.
Yiwen Li, Hongli Li, Mei-Nai Wang, Dan Lu, Rajiv Bassi

Blood· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DEGA/AMIGO-2, a leucine-rich repeat family member, differentially expressed in human gastric adenocarcinoma: effects on ploidy, chromosomal stability, cell adhesion/migration and tumorigenicity.
Karen E Rabenau, Jennifer M O'Toole, Rajiv Bassi, Helen Kotanides, Larry Witte

Oncogene· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
Douglas Burtrum, Zhenping Zhu, Dan Lu, Donna Marie Anderson, Marie Prewett, Rajiv Bassi

Cancer Res· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis.
Yiwen Li, Mei-Nai Wang, Hongli Li, Karen D King, Rajiv Bassi

J Exp Med· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
Fang Liao, Jacqueline F Doody, Jay Overholser, Bridget Finnerty, Rajiv Bassi

Cancer Res· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts.
Marie C Prewett, Andrea T Hooper, Rajiv Bassi, Lee M Ellis, Harlan W Waksal

Clin Cancer Res· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis